Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)
General Information of Drug (ID: DR0690) | ||||||
---|---|---|---|---|---|---|
Drug Name |
Fentanyl citrate
|
|||||
Synonyms |
Fentanest; Fentanil; Fentanil [DCIT]; Fentanila; Fentanila [INN-Spanish]; Fentanyl-100; Fentanyl-12; Fentanyl-25; Fentanyl-50; Fentanyl-75; Fentanylum; Fentanylum [INN-Latin]; Fentora; IONSYS; Matrifen; Phentanyl; Sentonil; Duragesic; Duragesic-100; Duragesic-12; Duragesic-25; Duragesic-50; Duragesic-75; Durogesic; Sublimase; Sublimaze; fentanyl; 1-Phenethyl-4-N-propionylanilinopiperidine; 437-38-7; N-(1-Phenethyl-4-piperidyl)propionanilide; N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide; N-Phenethyl-4-(N-propionylanilino)piperidine; FENTANYL CITRATE; Fentanyl citrate salt; Fentanyl dihydrogen citrate; Fentaz; MUN5LYG46H; McN-JR 4263; McN-JR-4263-49; Oralet; Phentanyl citrate; R 5240; SUBLIMAZE PRESERVATIVE FREE; 990-73-8; CHEBI:31602; EINECS 213-588-0; FENTANYL CITRATE PRESERVATIVE FREE; N-(1-Phenethyl-4-piperidinyl)propionanilide dihydrogen citrate; N-(1-Phenethyl-4-piperidyl)propionanilide citrate; N-(1-Phenethyl-4-piperidyl)propionanilide citrate (1:1); N-(1-Phenethyl-4-piperidyl)propionanilide dihydrogen citrate; UNII-MUN5LYG46H
|
|||||
Indication | Anaesthesia [ICD11: 8E22] | Approved | [1] | |||
Structure | ||||||
3D MOL is unavailable | 2D MOL | |||||
Pharmaceutical Properties | Molecular Weight | 528.6 | Topological Polar Surface Area | 156 | ||
Heavy Atom Count | 38 | Rotatable Bond Count | 11 | |||
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 9 | |||
Cross-matching ID |
|
|||||
The Metabolic Roadmap of This Drug | |||||
---|---|---|---|---|---|
The Full List of Drug Metabolites (DM) of This Drug | ||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
The Full List of Metabolic Reaction (MR) of This Drug | ||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.